Companion Diagnostic Development
We Build. We Validate. We Deliver.
ResearchDx integrates and aligns IVD and biopharma development that simplifies, speeds, and ensures delivery of your FDA-approved companion diagnostics on time.
ResearchDx integrates and aligns IVD and biopharma development that simplifies, speeds, and ensures delivery of your FDA-approved companion diagnostics on time.
Originally sourced from CMOCRO INOVIQ (IIQ) signs a contract services agreement with US-based contract diagnostics organisation ResearchDx to further develop and validate the company’s SubB2M-based tests in the US SubB2M-based tests are being developed for the monitoring and detection of cancer and its technology is based on an engineered protein that specifically detects the […]
Read MoreIrvine, CA —May 02, 2022 — ResearchDx will attend and exhibit at the ASCO Annual Meeting in Chicago, Il, June 3–7. Please visit our booth #22084, or call us at 760- 473-4295 to set up a consultation at the show.
Read More